Analystreport

Sarepta Therapeutics Inc (NASDAQ: SRPT) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating.

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report